Published in Ter Arkh on January 01, 2003
Local tolerance of intraarticular administration of lornoxicam into the rabbit knee joint. Rheumatol Int (2011) 0.76
Intra-articular injection of dexketoprofen in rat knee joint: histopathologic assessment of cartilage & synovium. Indian J Med Res (2014) 0.75
Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus (1995) 0.91
Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med (2002) 0.83
[The mechanism of the action of laser therapy in rheumatoid arthritis]. Ter Arkh (1994) 0.83
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
[Treatment of patients with gonarthrosis by intra-articular administration of drugs]. Klin Med (Mosk) (1989) 0.80
[Madecassol treatment of systemic and localized scleroderma]. Ter Arkh (1998) 0.79
[Corticosteroid therapy and aseptic bone necrosis in patients with rheumatoid arthritis]. Ter Arkh (1995) 0.78
[Cardiovascular diseases in rheumatoid arthritis]. Ter Arkh (2007) 0.77
[Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis]. Ter Arkh (2009) 0.77
[The von Willebrand factor antigen in patients with rheumatoid arthritis: a method for its determination and the clinical significance]. Ter Arkh (1993) 0.77
[The local therapy of enthesitis and bursitis of the calcaneal area in seronegative spondylarthritis]. Ter Arkh (1997) 0.76
[Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome]. Ter Arkh (2006) 0.76
[Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Ter Arkh (2008) 0.76
[The renin-angiotensin-aldosterone system and arterial hypertension in patients with rheumatoid arthritis]. Klin Med (Mosk) (1991) 0.75
[Cardiovascular risk in psoriatic arthritis]. Ter Arkh (2009) 0.75
[Pancreatic condition in systemic scleroderma]. Ter Arkh (1980) 0.75
[Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome]. Ter Arkh (1995) 0.75
[Haptoglobin and ceruloplasmin in systemic scleroderma]. Vopr Med Khim (1977) 0.75
[An assessment of tissue microcirculation in patients with aseptic femur head necrosis in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[Changes in the nervous system in children with different types of goiter before and after surgical treatment]. Pediatriia (1987) 0.75
[Treatment of Raynaud's syndrome with calcium entry blockers]. Ter Arkh (1987) 0.75
[Microcirculatory disorders in vasculitis of the skin]. Vestn Dermatol Venerol (1984) 0.75
[Experience in organizing a neurological service for children in the Bashkir ASSR]. Zdravookhr Ross Fed (1979) 0.75
[Use of laser Doppler flowmetry in various rheumatic diseases]. Revmatologiia (Mosk) (1988) 0.75
[Microcirculatory disorders in the skin in systemic scleroderma]. Ter Arkh (1979) 0.75
[Rate of absorption of Na24Cl and I-131-hippuran from the intramuscular depot]. Med Radiol (Mosk) (1970) 0.75
[Assessment of tissue microcirculation in patients with aseptic necrosis of femur heads in systemic lupus erythematosus (SLE)]. Ter Arkh (1999) 0.75
[The vasoprostan treatment of patients with Raynaud's syndrome]. Ter Arkh (1997) 0.75
[Nonrheumatic myocarditis (clinico-pathogenetic aspects)]. Ter Arkh (1982) 0.75
[Systemic sclerosis with a rapidly progressing course]. Ter Arkh (1981) 0.75
[Value of determination of skin microcirculation in systemic lupus erythematosus]. Ter Arkh (1979) 0.75
[Atheroscleotic vascular lesion in systemic lupus erythematosus and antiphospholipid syndrome in men]. Klin Med (Mosk) (2006) 0.75
Nucleic acid metabolism disturbance in progressive systemic sclerosis (systemic scleroderma). Clin Chim Acta (1978) 0.75
[Microcirculatory disorders in systemic scleroderma treated with d-penicillamine]. Klin Med (Mosk) (1981) 0.75
[Antiphospholipid syndrome and exogenic risk factors in thromboses]. Ter Arkh (2004) 0.75
[The condition of peripheral arteries in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2004) 0.75
[Status of tissue microcirculation in psoriatic arthritis]. Ter Arkh (1986) 0.75
[Methods for the instrumental diagnosis and verification of Lyme arthritis]. Ter Arkh (1997) 0.75
[Comparative evaluation of tissue microcirculation in patients with aseptic necrosis of the femur head in rheumatoid arthritis and systemic lupus erythematosus]. Ter Arkh (2001) 0.75
[Fibrinolytic system of blood in patients with hypertensive disease]. Ter Arkh (1974) 0.75
[Comparative evaluation of the treatment of Sjögren's syndrome with anti-rheumatic preparations]. Ter Arkh (1988) 0.75
[Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis]. Ter Arkh (2008) 0.75
[Clinical significance of the assessment of cardiac rhythm variability in patients with rheumatoid arthritis]. Klin Med (Mosk) (2009) 0.75
[Significance of bone marrow endothelial progenitor cells in disturbance of angiogenesis and endothelial dysfunction in systemic scleroderma]. Vestn Ross Akad Med Nauk (2008) 0.75
[Functional capacities of the body and their significance in the assessment of adolescents' health]. Gig Sanit (2000) 0.75
[Atherosclerotic lesion of the vessels in systemic lupus erythematosus in males: relations with concentration of C-reactive protein]. Ter Arkh (2005) 0.75
[Corticosteroids in the treatment of secondary antiphospholipid syndrome]. Klin Med (Mosk) (2002) 0.75
[Scleroderma]. Feldsher Akush (1980) 0.75
[Dermatomyositis associated with psoriasis]. Ter Arkh (1980) 0.75
[Microcirculatory disorders in patients with psoriatic arthritis]. Ter Arkh (1991) 0.75
[The clinical instrumental characteristics of the locomotor involvement in patients who have had Lyme disease]. Ter Arkh (1995) 0.75
[Mutation of a 5,10-methylenetetrahydrofolate reductase gene in systemic lupus erythematosis and antiphospholipid syndrome]. Ter Arkh (2002) 0.75
[Effect of combined treatment with nicotinic acid and DMSO on microcirculatory disorders in systemic scleroderma]. Ter Arkh (1978) 0.75
[Simplified method of simultaneous determination of the resorption rate of 2 radioindicators taken from the tissue]. Vopr Revm (1972) 0.75
[Hemodynamics and tolerance to physical exertion in patients with acute rheumatism]. Ter Arkh (1983) 0.75
[Clinico-instrumental evaluation of the laser therapy of rheumatoid arthritis]. Revmatologiia (Mosk) (1984) 0.75
[The effect of reserpine and isobarin on the blood coagulation system in patients with hypertensive disease]. Ter Arkh (1972) 0.75
[Treatment of systemic scleroderma with D-penicillin]. Ter Arkh (1977) 0.75
[Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients]. Ter Arkh (2009) 0.75
[Comparative clinico-immunologic and microcirculation studies in families of patients with type 1 diabetes mellitus and systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Intra-articular application of radioactive gold in infectious nonspecific polyarthritis]. Vopr Revm (1974) 0.75
[Articular lesions in Ixodes tick-borne borreliosis (Lyme disease)]. Vestn Ross Akad Med Nauk (2003) 0.75
[Biochemical diagnosis of kidney diseases in systemic scleroderma]. Ter Arkh (1979) 0.75
Plasma perfusion in treatment of cold rash and systemic lupus erythematosus. Lancet (1979) 0.75
[Differential diagnosis of diffuse eosinophilic fasciitis]. Revmatologiia (Mosk) (1990) 0.75
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)]. Ter Arkh (1985) 0.75
[Endothelial dysfunction in scleroderma systematica: clinicopathogenetic correlations]. Ter Arkh (2008) 0.75
[Nephropathy in a patient with systemic scleroderma treated with D-penicillamine]. Ter Arkh (1980) 0.75
[Primary antiphospholipid syndrome in combination with heterozygous mutation in prothrombin (G20210A) gene: a case report]. Klin Med (Mosk) (2002) 0.75
[Dimethylsulfoxide as a vehicle for vasoactive drugs in the treatment of systemic scleroderma]. Ter Arkh (1982) 0.75
[Present-day trends in adolescents' health]. Gig Sanit (2000) 0.75
[Sclerodermic pneumofibrosis (clinical-functional characteristics)]. Ter Arkh (1969) 0.75
[Urinary glycosaminoglycans in systemic scleroderma]. Ter Arkh (1980) 0.75
[Use of dimethylsulfoxide in complex therapy of patients with systemic scleroderma]. Ter Arkh (1977) 0.75
[Extracorporeal therapy (hemosorption, plasmapheresis) in the combined treatment of severe forms of Sjögren's disease]. Vutr Boles (1988) 0.75
[Soluble receptors of TNF-alpha: association with atherosclerotic vascular affection in systemic lupus erythematosus in males]. Ter Arkh (2006) 0.75
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]. Ter Arkh (1980) 0.75
[Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]. Ter Arkh (2003) 0.75
[Health status and reproductive functions in young women -- students of vocational schools]. Gig Sanit (1995) 0.75
[The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus]. Klin Med (Mosk) (2006) 0.75
[Muscular pathology in rheumatoid arthritis: a clinico-morphological study]. Klin Med (Mosk) (1996) 0.75
[Aggregation properties of thrombocytes in systemic diseases of the connective tissue]. Sov Med (1977) 0.75
[The cerebral blood circulation in patients with systemic lupus erythematosus and the antiphospholipid syndrome]. Ter Arkh (1994) 0.75
[The role of suprasegmental and segmental autonomic disorders in the development of muscular syndrome of rheumatoid arthritis]. Ter Arkh (2002) 0.75
[Clinical significance of heart rate variability in patients with systemic lupus erythematosus]. Ter Arkh (2008) 0.75
[Acute rheumatic polyarthritis in young men]. Ter Arkh (1991) 0.75
[Transcapillary metabolic disorders in systemic diseases of the connective tissue]. Vopr Revm (1977) 0.75
[Effect of vazaprostan on microcirculation in patients with scleroderma systematic]. Ter Arkh (2000) 0.75
[Microcirculatory disorders in the genesis of sclerodermic nephropathy]. Ter Arkh (1986) 0.75
[Thrombo ASS in the prophylaxis of vascular disorders in antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.75
[Place of hemocarboperfusion and hyperbaric oxygenation in the treatment of patients with rheumatoid arthritis with systemic symptoms]. Ter Arkh (1986) 0.75
Microcirculation disorders in systemic connective tissue diseases. Bibl Anat (1975) 0.75
[Effect of hyperbaric oxygenation on the microcirculatory state in clinically manifest rheumatoid vasculitis]. Ter Arkh (1982) 0.75
[Vascular symptoms of Behcet's disease]. Ter Arkh (2005) 0.75
[Systemic scleroderma]. Med Sestra (1978) 0.75